Gram-positive and gram-negative bacteria are distinct types of bacteria. Learn more here. ... • Escherichia coli • Bartonella henselae • Campylobacter • Legionella • Salmonella ...

New antibiotic targets only gram-negative bacteria, ... Lolamicin was especially effective against Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in mice.

Gram-negative bacteria comprise most of the CDC and WHO’ ... with Escherichia coli being the most common organism and 3.7% of patients having an MBL-producing organism.

A synthetic molecule modified from an existing antibiotic may be effective against more than 200 Gram-negative bacteria that are drug resistant. ... drug-resistant strain of Escherichia coli.

[1,2] The gram-negative bacilli most commonly responsible for infection in humans are Enterobacter species, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Acinetobacter species ...

Laboratory studies, using the tube-dilution method of determining the sensitivity of organisms to penicillin, indicated that the bulk of strains of gram-negative organisms such as Escherichia coli ...

One of the new compounds, lolamicin, selectively targeted some laboratory strains of gram-negative pathogens including Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae, the ...

Teleflex Incorporated (NYSE: TFX) has announced findings from a new multinational study demonstrating the efficacy of its ...

In it, the researchers describe how an imbalance in the three-part protein complex — MacAB-TolC—helps gram-negative bacteria resist antibiotics. The MacAB-TolC complex, known as a multidrug ...

Two infectious disease experts at Johns Hopkins Medicine have been awarded $10 million in research funding over five years by the Patient-Centered Outcomes Research Institute (PCORI).

Lolamicin was especially effective against Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in mice. Importantly, the antibiotic also appeared to leave commensal bacteria alone ...